> News
 > Microbiotica unveils multiple mechanisms by which MB310, in clinical development for the treatment of ulcerative colitis, protects the intestinal barrier
News
09/05/2025

Microbiotica unveils multiple mechanisms by which MB310, in clinical development for the treatment of ulcerative colitis, protects the intestinal barrier

Read the full article below.

microbiotica

Our news

News
05/06/2025
The European Microbiome Innovation for Health Association Welcomes 13 New Members, Strengthening Europe’s Leadership in Microbiome Innovation
> READ
News
21/07/2025
EMIH response to the European Commission call for evidence on the EU Biotech Act
> READ
News
14/05/2024
The Alliance Promotion Microbiote is becoming the European Microbiome Innovation for Health: a major step towards structuring the European microbiome excellence sector
> READ
> See all news

EMIH response to the European Commission call for evidence on the EU Biotech Act